In a regulatory filing, Cue Biopharma (CUE) disclosed that on June 4, Kerri-Ann Millar notified the company that she is resigning from her position as Chief Financial Officer, effective June 13. Effective June 13, Daniel Passeri, the company’s Chief Executive Officer, will serve as the company’s principal financial and accounting officer on an interim basis until a new principal financial and accounting officer is designated, the filing stated.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUE: